Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.1 EUR | +1.74% | +3.54% | -12.73% |
Apr. 25 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 02 | Boiron: nearly 600,000 shares tendered to the OPAS | CF |
Business Summary
Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin.
There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties).
BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries.
Net sales are distributed geographically as follows: France (47.9%), Europe (24.7%), North America (24.4%) and other (3%).
Number of employees: 2,656
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Homeopathic Specialties
57.0
%
| 280 | 52.4 % | 281 | 57.0 % | +0.47% |
Common Name Homeopathic Medicines
36.0
%
| 185 | 34.6 % | 178 | 36.0 % | -3.76% |
Other Health Products
7.0
%
| 70 | 13.1 % | 34 | 7.0 % | -50.63% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
France
47.9
%
| 280 | 52.4 % | 236 | 47.9 % | -15.65% |
Europe
24.7
%
| 120 | 22.5 % | 122 | 24.7 % | +1.17% |
North America
24.4
%
| 121 | 22.6 % | 120 | 24.4 % | -0.10% |
Other Countries
3.0
%
| 13 | 2.5 % | 15 | 3.0 % | +11.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 11-06-30 | |
Thierry Boiron
CHM | Chairman | 63 | 96-09-17 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hervé Coulpier
CTO | Chief Tech/Sci/R&D Officer | - | 17-04-30 |
Patrice Varraut
COO | Chief Operating Officer | - | 08-12-31 |
Fabrice Rey
IRC | Investor Relations Contact | - | - |
Juliette Baudry
HRO | Human Resources Officer | - | - |
Frédéric Ducher
LAW | General Counsel | - | 15-05-31 |
Eric Lambert
SEC | Corporate Secretary | - | 19-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 80 | 03-05-21 | |
Thierry Boiron
CHM | Chairman | 63 | 96-09-17 |
Philippe Brun
BRD | Director/Board Member | 64 | 21-05-26 |
Jacky Abécassis
BRD | Director/Board Member | 79 | 87-05-05 |
Michéle Boiron
BRD | Director/Board Member | 79 | 96-09-17 |
Chief Executive Officer | 55 | 11-06-30 | |
Anne Borfiga
BRD | Director/Board Member | 52 | 21-05-26 |
Director/Board Member | 49 | 13-05-22 | |
Grégory Walter
BRD | Director/Board Member | 46 | 17-05-17 |
Director/Board Member | 53 | 21-12-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,545,408 | 2,265,995 ( 12.92 %) | 183,133 ( 1.044 %) | 12.92 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Boiron Laboratories Pvt Ltd.
|
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.60% | 652M | |
+42.07% | 6.23B | |
-21.20% | 4.19B | |
+5.38% | 3.32B | |
-16.98% | 2.91B | |
-5.82% | 2.42B | |
+45.47% | 1.94B | |
-12.67% | 1.59B | |
-3.91% | 1.58B | |
+44.56% | 1.49B |
- Stock Market
- Equities
- BOI Stock
- Company BOIRON